What is CG Oncology's net investment in lease?

CG Oncology (CGON) reported net investment in lease of $4.51M in Q1 2026.

How has CG Oncology's net investment in lease changed year-over-year?

CG Oncology's net investment in lease increased by 336.8% year-over-year, from $1.03M to $4.51M.

What is the long-term trend for CG Oncology's net investment in lease?

Over 2 years (2023 to 2025), CG Oncology's net investment in lease has grown at a 206.8% compound annual growth rate (CAGR), from $422K to $3.97M.

CG Oncology CGON Net Investment in Lease

Net Investment in Lease at other companies

ImmunityBio, Inc.IBRX

——

Cogent Biosciences, Inc.COGT

——

Tango TherapeuticsTNGX

——

Summit TherapeuticsSMMT

——

CRISPR TherapeuticsCRSP

——

BiogenBIIB

——

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Enterprise value$5.36B+212%

P/S1,062.4×-1,596×

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's net investment in lease?: CG Oncology (CGON) reported net investment in lease of $4.51M in Q1 2026.
How has CG Oncology's net investment in lease changed year-over-year?: CG Oncology's net investment in lease increased by 336.8% year-over-year, from $1.03M to $4.51M.
What is the long-term trend for CG Oncology's net investment in lease?: Over 2 years (2023 to 2025), CG Oncology's net investment in lease has grown at a 206.8% compound annual growth rate (CAGR), from $422K to $3.97M.